# Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | — |
| 2024 | $87M |
| 2023 | $381M |
| 2022 | $22M |
| 2021 | $285,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2025-09-30 | — |
| 2025-06-30 | — |
| 2025-03-31 | — |
| 2024-09-30 | $416,000 |
| 2024-06-30 | -$1M |
| 2024-03-31 | $89M |
| 2023-09-30 | $103M |
| 2023-06-30 | $98M |
| 2023-03-31 | $71M |
| 2022-09-30 | $345,000 |
| 2021-09-30 | $285,000 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/AMLX/revenue)
